KILITCHPharmaceuticals
Kilitch Drugs India Ltd — PE Ratio & Valuation Analysis
₹124.45
-9.06%
Current P/E21.74xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E36.1x39.9% below avg
✅
31.6% Discount to Industry
KILITCH P/E 21.74x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹16.60 | ₹350 | 21.1x |
| 2024 | ₹9.17 | ₹326 | 35.6x |
| 2023 | ₹6.71 | ₹369 | 55x |
| 2022 | ₹4.73 | ₹156 | 32.9x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Kilitch Drugs India Ltd Valuation
Kilitch Drugs India Ltd (KILITCH) currently trades at 21.74x earnings. The Pharmaceuticals sector average PE is 31.77x. KILITCH is trading at a discount to peers — may indicate relative value. Historically, KILITCH has traded at an average PE of 36.1x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
12.61%
Dividend Yield
0.00%
More on Kilitch Drugs India Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.